Anticoagulants and Osteoporosis
From: Service des maladies osseuses, Département de rehabilitation et gériatrie, HUG, 1211 Genève.
Revue médicale suisse
- Publish Date: Jun 2007
- ISSN: 1660-9379
- Volume: 3
- Issue: 115
- Pages: 1508-11
- Medium: Print
- Language:
- Citation (JAMA): Ferrière Karine, Rizzoli René, et al. Anticoagulants and Osteoporosis. Jun 2007;3:1508-11
Abstract
There are numerous indications for anticoagulant therapy. It has been suggested that such a therapy threatened bone health and could represent a risk factor for osteoporosis. After a careful review of the literature, it is difficult to conclude that anticoagulant treatment is a significant risk factor for fracture. In any case, a possible fracture risk has to be balanced against the indications for an anticoagulant treatment.
Mesh Headings (Keywords): Anticoagulants, Bone Density, Fractures, Bone, Heparin, Heparin, Low-Molecular-Weight, Humans, Osteoporosis, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 17682793
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.